However, aberrant overexpression of EVI1 is a hallmark of aggressive myeloid leukemias, including acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and the blast crisis of chronic myeloid leukemia (CML). Here, RUNX1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.